-
Amgen to expand its area roots with major investment
19 Sep 2025 00:37 GMT
… of scientific discovery,” Amgen Chairman and CEO Robert A. Bradway … significant this investment by Amgen will be for Ventura … annual comprehensive financial report.
Amgen’s announcement follows other … will remain central to Amgen’s future.
Ventura County …
-
Samsung Biologics, Amgen and Biocon invest in US pharma sites
15 Sep 2025 17:47 GMT
… U.S. expansion opportunities.
Amgen to invest more than $600 … were disclosed.
It builds on Amgen’s previous investments, including a … and Jobs Act of 2017. Amgen designated about $5 billion … , Siddharth Mittal, Biocon’s CEO and managing director, said in …
-
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
19 Sep 2025 11:45 GMT
… ®,” said Robert Wessman, chairman and CEO of Alvotech. “We look forward … ® is a registered trademark of Amgen, Stelara® and Simponi® are a …
-
Lilly to build $5bn biologics manufacturing plant in Virginia
18 Sep 2025 07:36 GMT
… Washington DC. At the time, CEO David Ricks said, “This bold … local and state officials.
Related:Amgen credits tax initiatives as helping …
-
Biocon Biologics gets US FDA nod for two drugs to treat osteoporosis, bone loss
18 Sep 2025 00:43 GMT
… Aukelso (denosumab-kyqq), biosimilars of Amgen’s Prolia and Xgeva, respectively … $1.6 billion.
Biocon Biologics CEO & MD Shreehas Tambe said …
-
Gordon Reid’s Top Picks for September 17, 2025
17 Sep 2025 22:43 GMT
… Amgen, Qualcomm & United Rentals Gordon Reid, President & CEO at … in the market.
Amgen (AMGN NASD)
Amgen offers wide appeal on … per cent dividend yield, Amgen is a solid holding. … Gordon Reid, President & CEO at Goodreid Investment Counsel, …
-
FDA Approves Bosaya and Aukelso, Biosimilars to Reference Denosumab
17 Sep 2025 19:33 GMT
… denosumab (Prolia and Xgeva, respectively; Amgen). Additionally, the FDA granted provisional … oncology care portfolio,” Shreehas Tambe, CEO and managing director of Biocon …
-
GSK outlines $30bn, five-year plan for R&D and manufacturing in the US
17 Sep 2025 16:36 GMT
… ’ ties in science and medicine.
CEO Emma Walmsley said: “Alongside the … &J, Lilly, Gilead, AbbVie, Amgen and UCB as President Trump …
-
Ollin debuts with $100M and plans to challenge top-selling eye drugs
17 Sep 2025 10:50 GMT
… vision loss drug Vabysmo and Amgen’s thyroid eye disease treatment … Eylea to Vabysmo now,” said CEO Jason Ehrlich. “So therapies that …
-
Noxopharm targets the ‘burning fire’ of inflammation
16 Sep 2025 20:34 GMT
… skin lupus
Noxopharm (ASX:NOX) CEO and managing director Dr Gisela … at MSD (Merck), Bayer and Amgen.
The well-credentialled Mautner holds …
About
© 1995-2025